Treatment of Ocular Infections with Topical Antibacterials

[1]  J. Baum,et al.  Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review , 1999 .

[2]  J. Blondeau.  A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'. , 1999, The Journal of antimicrobial chemotherapy.

[3]  T. Lancaster,et al.  Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database , 1998, BMJ.

[4]  S. Shapiro,et al.  Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies , 1998, BMJ.

[5]  E. Romanowski,et al.  Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model. , 1997, Investigative ophthalmology & visual science.

[6]  K. Bower,et al.  Fluoroquinolones in the treatment of bacterial keratitis. , 1996, American journal of ophthalmology.

[7]  D. Fong,et al.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. , 1996, Archives of ophthalmology.

[8]  M. Maguire,et al.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. , 1995, Archives of ophthalmology.

[9]  J. Diamond,et al.  Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration. , 1995, The British journal of ophthalmology.

[10]  J. Baum.  Infections of the eye. , 1987, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  R. de Natale,et al.  Collagen shields delivery of netilmicin: a study of ocular pharmacokinetics. , 1995, Chemotherapy.

[12]  James M. Hill,et al.  Pharmacokinetic Considerations in the Treatment of Bacterial Keratitis , 1994, Clinical pharmacokinetics.

[13]  J. Diamond,et al.  Ocular penetration of topical ciprofloxacin and norfloxacin drops and their effect upon eyelid flora. , 1994, The British journal of ophthalmology.

[14]  R. Snyder,et al.  Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor. , 1994, Ophthalmology.

[15]  H. Kaufman,et al.  Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis. , 1994, Current eye research.

[16]  G. Grass,et al.  A model to predict aqueous humor and plasma pharmacokinetics of ocularly applied drugs. , 1993, Investigative ophthalmology & visual science.

[17]  A. Yunis,et al.  Blood dyscrasias and topical ophthalmic chloramphenicol. , 1993, American journal of ophthalmology.

[18]  D. J. Parks,et al.  Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. , 1993, American journal of ophthalmology.

[19]  J. Cowden,et al.  Corneal stromal penetration of topical ciprofloxacin in humans. , 1993, Ophthalmology.

[20]  V. Huerva,et al.  Levels of vancomycin in aqueous humor after topical eye drops administration. , 1993, Journal of ocular pharmacology.

[21]  A. Gwon.  Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group. , 1992, The British journal of ophthalmology.

[22]  M. Snyder,et al.  Ciprofloxacin-resistant bacterial keratitis. , 1992, American journal of ophthalmology.

[23]  A. Gwon.  Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II. , 1992, Archives of ophthalmology.

[24]  E. Lin,et al.  Ofloxacin in Human Serum, Urine, and Tear Film After Topical Application , 1992, Cornea.

[25]  A. Péchinot,et al.  Ocular penetration of topically applied norfloxacin 0.3% in the rabbits and in humans. , 1992, Journal of ocular pharmacology.

[26]  A. Bron,et al.  Ofloxacin compared with chloramphenicol in the management of external ocular infection. , 1991, The British journal of ophthalmology.

[27]  H. Leibowitz.  Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. , 1991, American journal of ophthalmology.

[28]  H. Leibowitz.  Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. , 1991, American journal of ophthalmology.

[29]  F. Gardner.  Chloramphenicol: a dangerous drug? , 1991, Acta haematologica.

[30]  D. Tang-Liu,et al.  Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms , 1990, Antimicrobial Agents and Chemotherapy.

[31]  N. Sinclair,et al.  A comparison of fusidic acid viscous eye drops and chloramphenicol eye ointment in acute conjunctivitis , 1988 .

[32]  W. George,et al.  Topical vs systemic gentamicin penetration into the human cornea and aqueous humor. , 1987, Archives of ophthalmology.

[33]  J. Hvidberg,et al.  Fusidic acid in acute conjunctivitis , 1987, Acta ophthalmologica.

[34]  V. H. Lee,et al.  Topical ocular drug delivery: recent developments and future challenges. , 1986, Journal of ocular pharmacology.

[35]  T. Lesar,et al.  Antimicrobial Drug Delivery to the Eye , 1985, Drug intelligence & clinical pharmacy.

[36]  D. Glasser,et al.  Loading doses and extended dosing intervals in topical gentamicin therapy. , 1985, American journal of ophthalmology.

[37]  G. Grass,et al.  Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability. , 1984, Journal of pharmaceutical sciences.

[38]  J. Lohr,et al.  Efficacy of topical antibiotic therapy in acute conjunctivitis in children. , 1984, The Journal of pediatrics.

[39]  T. Zimmerman,et al.  Improving the therapeutic index of topically applied ocular drugs. , 1984, Archives of ophthalmology.

[40]  A. Friedman,et al.  Drug reservoirs in topical therapy. , 1984, Investigative ophthalmology & visual science.

[41]  J. Rissing,et al.  Iontophoresis of gentamicin into aphakic rabbit eyes. Sustained vitreal levels. , 1984, Investigative ophthalmology & visual science.

[42]  G. Chader,et al.  PHARMACOLOGY OF THE EYE , 1984, Handbook of Experimental Pharmacology.

[43]  F. Fraunfelder,et al.  Ocular chloramphenicol and aplastic anemia. , 1983, The New England journal of medicine.

[44]  J. R. Gibson.  Trimethoprim-polymyxin B ophthalmic solution in the treatment of presumptive bacterial conjunctivitis--a multicentre trial of its efficacy versus neomycin-polymyxin B-gramicidin and chloramphenicol ophthalmic solutions. , 1983, The Journal of antimicrobial chemotherapy.

[45]  G. Trope,et al.  Systemic absorption of topical and subconjunctival gentamicin. , 1979, The British journal of ophthalmology.

[46]  G. Trope,et al.  Systemic absorption of topically applied chloramphenicol eyedrops. , 1979, The British journal of ophthalmology.

[47]  M. Doane,et al.  Penetration routes of topically applied eye medications. , 1978, American journal of ophthalmology.

[48]  T. F. Patton,et al.  Ocular bioavailability and systemic loss of topically applied ophthalmic drugs. , 1978, American journal of ophthalmology.

[49]  R. Hyndiuk,et al.  Corticosteroid in experimentally induced Pseudomonas keratitis: failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy. , 1978, Archives of ophthalmology.

[50]  R. Hyndiuk,et al.  Topical tobramycin therapy of experimental Pseudomonas keratitis: an evaluation of some factors that potentially enhance efficacy. , 1978, Archives of ophthalmology.

[51]  J. Robinson,et al.  Mechanistic studies on transcorneal permeation of pilocarpine. , 1976, Journal of pharmaceutical sciences.

[52]  H. Leibowitz,et al.  Human conjunctivitis. I. Diagnostic evaluation. , 1976, Archives of ophthalmology.

[53]  N. Jarudi,et al.  Ocular penetration of topically applied gentamicin. , 1975, Archives of ophthalmology.

[54]  N. Jarudi,et al.  Comparison of antibiotic therapy in presumptive bacterial conjunctivitis. , 1975, American journal of ophthalmology.

[55]  H. A. Baldwin,et al.  Chloramphenicol in aqueous humor after topical application. , 1975, Archives of ophthalmology.

[56]  J. Baum,et al.  Concentration of gentamicin in experimental corneal ulcers. Topical vs subconjunctival therapy. , 1974, Archives of ophthalmology.

[57]  H. Benson.  Permeability of the cornea to topically applied drugs. , 1974, Archives of ophthalmology.

[58]  J. Robinson,et al.  Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. , 1974, Journal of pharmaceutical sciences.

[59]  Francis O'Grady,et al.  ANTIBIOTIC AND CHEMOTHERAPY , 1974, The Ulster Medical Journal.

[60]  D. Maurice.  The dynamics and drainage of tears. , 1973, International ophthalmology clinics.

[61]  P. Noone,et al.  Therapeutic implications of interaction of gentamicin and penicillins. , 1971, Lancet.